Scholar Rock Holding (SRRK) Shareholder's Equity (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 276.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 276.01 Mn |
| Dec 31, 2025 | 245.49 Mn |
| Sep 30, 2025 | 245.00 Mn |
| Jun 30, 2025 | 233.29 Mn |
| Mar 31, 2025 | 312.33 Mn |
| Dec 31, 2024 | 368.63 Mn |
| Sep 30, 2024 | 79.20 Mn |
| Jun 30, 2024 | 133.62 Mn |
| Mar 31, 2024 | 182.77 Mn |
| Dec 31, 2023 | 225.22 Mn |
| Sep 30, 2023 | 167.67 Mn |
| Jun 30, 2023 | 202.50 Mn |
| Mar 31, 2023 | 228.65 Mn |
| Dec 31, 2022 | 260.24 Mn |
| Sep 30, 2022 | 293.27 Mn |
| Jun 30, 2022 | 329.51 Mn |
| Mar 31, 2022 | 171.32 Mn |
| Dec 31, 2021 | 172.07 Mn |
| Sep 30, 2021 | 187.26 Mn |
| Jun 30, 2021 | 216.66 Mn |
| Mar 31, 2021 | 240.54 Mn |
| Dec 31, 2020 | 260.77 Mn |
| Sep 30, 2020 | 62.98 Mn |
| Jun 30, 2020 | 82.17 Mn |
| Mar 31, 2020 | 98.65 Mn |
| Dec 31, 2019 | 112.90 Mn |
| Sep 30, 2019 | 121.79 Mn |
| Jun 30, 2019 | 128.96 Mn |
| Mar 31, 2019 | 97.52 Mn |
| Dec 31, 2018 | 106.62 Mn |
| Sep 30, 2018 | 102.34 Mn |
| Jun 30, 2018 | 111.61 Mn |
| Mar 31, 2018 | -61.93 Mn |
| Dec 31, 2017 | -53.52 Mn |